Journal article
Authors list: Kulzer, B.; Hermanns, N.; Kruse, J.
Publication year: 2010
Pages: 255-265
Journal: Der Diabetologe
Volume number: 6
Issue number: 4
ISSN: 1860-9716
DOI Link: https://doi.org/10.1007/s11428-009-0531-9
Publisher: Springer
Abstract:
Compared with the general population diabetic patients have a clearly increased risk of suffering from depressive symptoms (subclinical form) or to develop depression (according the ICD or DSM criteria), which can represent a significant barrier to achieving the goals of diabetes therapy. The co-morbidity of depression and diabetes has a negative impact on the patient's disease management, quality of life, glycaemic control, risk for late complications and mortality. Neuroendocrine alterations, disease-specific impact, direct and indirect effects on glycaemic control as well as impaired coping ability and strategies are all discussed as possible causes. Although effective interventions for the management of depression in diabetic patients exist, in clinical practise, patients with depression remain to a large extent unrecognised and untreated.
Citation Styles
Harvard Citation style: Kulzer, B., Hermanns, N. and Kruse, J. (2010) Diabetes und Depression. Risiken und Zusammenhänge, Der Diabetologe, 6(4), pp. 255-265. https://doi.org/10.1007/s11428-009-0531-9
APA Citation style: Kulzer, B., Hermanns, N., & Kruse, J. (2010). Diabetes und Depression. Risiken und Zusammenhänge. Der Diabetologe. 6(4), 255-265. https://doi.org/10.1007/s11428-009-0531-9
Keywords
COMORBID DEPRESSION; DEPRESSED MOOD; GLYCEMIC CONTROL; MAJOR DEPRESSION; Quality of life; SYMPTOMS